Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ:CDIO)

1.265 -0.025 (-1.94%)
Streaming Delayed Price Updated: 2:28 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 Next >
News headline image
Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease
From Cardio Diagnostics Holdings Inc.
Via Business Wire
News headline image
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
From Cardio Diagnostics Holdings Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
From Cardio Diagnostics Holdings
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations
From Cardio Diagnostics
Via Business Wire
News headline image
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis Death
News headline image
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
Via AB Newswire
Topics Artificial Intelligence Government
News headline image
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
News headline image
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
Via AB Newswire
News headline image
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
By Jeremy Golden, Benzinga 
Via TheNewswire.com
News headline image
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
News headline image
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.